Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118619879A details a novel Rhodium-catalyzed route for trifluoromethyl enaminones, offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN107235967B reveals a green, mild synthesis of Tegafur using 5-fluorouracil and THF. Discover cost-effective manufacturing strategies for high-purity antineoplastic intermediates.
Novel Raney Nickel catalytic method reduces energy and solvent costs for pharmaceutical intermediate manufacturing supply chain efficiency and high purity output.
Novel metal-free route for trifluoromethyl 1,2,4-triazines. High yields, mild conditions, scalable process for API intermediates.
Novel Rh-catalyzed oxidative coupling method for 2-methylene-1-indanone derivatives. Offers high purity, simplified workflow, and cost-effective API intermediate manufacturing solutions.
Patent CN115286578B reveals metal-free synthesis enhancing purity and supply chain reliability for high-purity trifluoromethyl-containing pyrazole compound manufacturing processes globally.
Novel heterogeneous catalytic method for benzimidazole synthesis offering mild conditions and recyclable catalysts for cost-effective production.
Patent CN111285846B details a novel Rh-catalyzed C-H activation route for 2-(2-indolyl)-acetates, offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN118638038B reveals novel chiral isothiourea catalysis for high-purity indole amides. Enables cost reduction and scalable supply chain for pharmaceutical intermediates manufacturing.
Patent CN112125856A reveals a safe palladium-catalyzed route to 2-trifluoromethyl quinazolinones using solid CO surrogates, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN102060761B reveals a metal-free iodine-catalyzed route for quinoline derivatives, offering significant cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN116813544B reveals metal-free heating method for quinoline synthesis offering supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for anticancer drug development.
Novel Pd-catalyzed bis-carbonylation route offers high yields and substrate tolerance for scalable pharmaceutical intermediate manufacturing.
Patent CN108484499B reveals a green rhodium-catalyzed route for isoquinoline synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110467640B reveals a novel Mn-promoted synthesis for phosphorus-containing heterocycles, offering cost reduction in API manufacturing and scalable production.
Novel nitrile hydratase method for Eluxadoline intermediate offers high yield and mild conditions, ensuring reliable supply chain and cost efficiency.
Patent CN113735778B reveals efficient Ag2O promoted route. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing globally.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Patent CN109851599B details a novel one-pot synthesis of 2-aminobenzofurans using TIPS-EBX. This method offers high yields and simplified purification for pharmaceutical intermediates.